Home > Insider Trading > Filing (0001209191-20-037706)

Filing Details

Accession Number:: 0001209191-20-037706
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-18 18:19:14
Reporting Period:: 2020-06-12

Accepted Time:: 2020-06-18 18:19:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1006028	Pure Bioscience Inc.	PURE	Miscellaneous Chemical Products (2890)	330530289

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1623609	Y Tom Lee	1807 San Gabriel Blvd. San Gabriel CA 91776	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-12	45,157	$1.91	4,407,647	No	4	P	Direct
Common Stock	Acquisiton	2020-06-15	60,000	$1.82	4,467,647	No	4	P	Direct
Common Stock	Acquisiton	2020-06-16	70,000	$1.62	4,537,647	No	4	P	Direct
Common Stock	Acquisiton	2020-06-17	26,876	$1.61	4,564,523	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	24,134,173	Indirect	By Plum Investments, L.P.
Common Stock	1,000,000	Indirect	By Kamika Shay Lee Trust Dated July 1, 2019
Common Stock	1,000,000	Indirect	By Karissa Shay Lee Trust Dated July 1, 2019
Common Stock	1,000,000	Indirect	By Tessa Melody Shin Trust Dated February 12, 2020
Common Stock	717,665	Indirect	Wife

Footnotes

This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.89 to $1.94. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.72 to $1.88. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.40 to $1.74. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.38 to $1.70. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.
Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019, Karissa Shay Lee Trust Dated July 1, 2019 and Tessa Melody Shin Trust Dated February 12, 2020 and has voting and dispositive power with respect to these shares